The goal of this SCOR project is to further the understanding of the fundamental mechanism of congenital heart disease with the use of the state-of-the-art technology of molecular biology, developmental biology, human genetics, small animal cardiac physiology, and clinical pediatric cardiology. The Harvard SCOR in Pediatric Cardiology would bring together some of the finest basic science research faculty of the Harvard Medical School and its affiliated teaching hospitals. Each participant of this SCOR has a strong track record of making original and fundamental contributions to cardiovascular sciences as it relates to the aim of this RFA. The projects described in this SCOR application are designed to take the maximum advantage of studying the closely related scientific theme using the different model organisms and system to dissect the role of transcription factors and secreted factors in the cardiac morphogenesis and their mutations in human and in experimental animals, as well as their linkage into the population of pediatric patients with congenital heart disease. Accordingly, this Harvard SCOR application is entitled """"""""Molecular Mechanisms of Congenital Heart Disease,"""""""" and consists of five independent but highly interactive projects and three cores that provide highly specialized technological support as well as administrative support to facilitate the progress of each project. Specific projects include: Project I: Functional Analysis of the Cardiac Specific Homeobox Gene Csx/Nkx (P.I.-Seigo, Izumo). Project II: Genetic Analytic of Inherited Congenital Heart Diseases (P.I.-Christine E. Seidman; Co-P.I.-Jon Seidman). Project III. Identification of Signaling Molecules that Induce Heart Formation (P.I.-Andrew B. Lasser). Project IV: T-Box Gene in Congenital Heart and Limb Deformities (P.I.-Clifford J. Tabin). Project V: Genetic Determinants of Arrythmia Development Associated with Congenital Heart Malformation (P.I.-Charles I. Berul; Co-Investigators Mark E. Josephson and Edward Walsh). Small Animal Physiology Core (Director- James P. Morgan) will provide the state-of-the-art physiological analysis of the murine cardiovascular system using a multi-disciplinary approach. The Embryo Physiology and Imaging Laboratory will be a unique resource to the Harvard community. Morphology Core will be developed to facilitate morphological studies by each Project. The program is designed to have clear focus on the investigations of the molecular basis for cardiac development and their genetic alterations with particular emphasis on the studies of cardiac transcription factors and secreted factors that play critical roles in early cardiogenesis. All projects are extensively interconnected both in scientific theme and the technological aspects while taking advantage of both experimental and clinical methodologies. The program unites both basic science departments and clinical cardiology programs of Harvard Medical Campus. The SCOR Director has extensive experiences in organizing interactive multi-disciplinary programs that encompasses both clinical and academic disciplines. The SCOR has full institutional support to make the program successful. We believe that this SCOR will generate many new findings fundamental to our understanding of congenital heart disease and at the same time is designed to provide rich training opportunities for the next generation of cardiovascular scientists and clinicians.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL061036-01
Application #
2707251
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (S1))
Project Start
1999-01-01
Project End
2003-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Pu, William T; Ishiwata, Takahiro; Juraszek, Amy L et al. (2004) GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275:235-44
Kasahara, Hideko; Ueyama, Tomomi; Wakimoto, Hiroko et al. (2003) Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol 35:243-56
Ueyama, Tomomi; Kasahara, Hideko; Ishiwata, Takahiro et al. (2003) Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. Mol Cell Biol 23:9222-32
Ishiwata, Takahiro; Nakazawa, Makoto; Pu, William T et al. (2003) Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. Circ Res 93:857-65
Ueyama, Tomomi; Kasahara, Hideko; Ishiwata, Takahiro et al. (2003) Csm, a cardiac-specific isoform of the RNA helicase Mov10l1, is regulated by Nkx2.5 in embryonic heart. J Biol Chem 278:28750-7
Rallis, Charalampos; Bruneau, Benoit G; Del Buono, Jo et al. (2003) Tbx5 is required for forelimb bud formation and continued outgrowth. Development 130:2741-51
Wakimoto, Hiroko; Kasahara, Hideko; Maguire, Colin T et al. (2002) Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA nonbinding mutant Nkx2.5. J Cardiovasc Electrophysiol 13:682-8
Triedman, John K; Alexander, Mark E; Love, Barry A et al. (2002) Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 39:1827-35
Kardon, Gabrielle; Campbell, Jacquie Kloetzli; Tabin, Clifford J (2002) Local extrinsic signals determine muscle and endothelial cell fate and patterning in the vertebrate limb. Dev Cell 3:533-45
Rakhit, A; Maguire, C T; Wakimoto, H et al. (2001) In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. J Cardiovasc Electrophysiol 12:1295-301

Showing the most recent 10 out of 16 publications